(redirected from Nephrogenic fibrosing dermopathy)
Also found in: Medical, Wikipedia.
NFDNephrogenic Fibrosing Dermopathy
NFDNo Floppy Drive (computer hardware)
NFDnot for Distribution
NFDNashville Fire Department (Tennessee)
NFDNational Foundation for the Deaf, Inc. (New Zealand)
NFDNo Further Details
NFDNot Following Directions (education)
NFDNon-Financial Disclosure (corporate governance)
NFDNodal Fault Diagnostics (US DoD)
NFDNet Filter Discrimination (radio)
NFDNet Financial Debt
NFDNational Forest Development (Road)
NFDNo Foreign Dissemination
NFDNetwork Flow Diagrams
NFDNoise Flash Device
NFDNavy Fuel Depot
NFDNumber of Faults Detected
NFDNorthern Federation of Draughts (Northern Ireland)
NFDNa Fianna Dragun (gaming guild)
NFDNuclear Fuels Division
NFDNewberg Fire Department (Newberg, Oregon)
References in periodicals archive ?
We searched the autopsy records of the Department of Pathology at the Massachusetts General Hospital from 2004-2008 for the diagnostic terms nephrogenic systemic fibrosis and nephrogenic fibrosing dermopathy.
According to the International Center for Nephrogenic Fibrosing Dermopathy Research (ICNFDR), patients with NFD/NSF experience swelling and tightening of the skin with induration usually involving the distal extremities, but sometimes involving the trunk (Cowper, 2008).
Nephrogenic fibrosing dermopathy (NFD) is marked by areas of tight, rigid skin and may progress to nephrogenic systemic fibrosis (NSF), which is associated with scarring of internal organs.
Nephrogenic fibrosing dermopathy was gradually observed as not merely a cutaneous process--but a systemic one.
Update on magnetic resonance imaging (MRI) contrast agents containing gadolinium and nephrogenic fibrosing dermopathy.
The term nephrogenic fibrosing dermopathy (NFD) was introduced in 2001.
Nephrogenic fibrosing dermopathy was first described several years ago by Dr.
Nephrogenic fibrosing dermopathy is a newly identified skin disorder that appears to be strongly associated with renal disease, dialysis, and renal transplantation.
Hence, the name nephrogenic systemic fibrosis is now used instead of nephrogenic fibrosing dermopathy to reflect the multisystem nature of the disease.
Clinically and histopathologically, however, the disorder is distinctly different from scleromyxedema and the term nephrogenic fibrosing dermopathy (NFD) was used to designate the disorder as a new clinical-pathological entity.